New eBook: The role of real-world evidence in FDA approvals. Download now.
Leadership Team
We are an experienced and optimistic team, deeply committed to a data-driven transformation of health care.

Carolyn is a health care technology executive with over 20 years of leadership experience in driving the transition from fee-for-service to value-based care.
Read more
Jeremy is an epidemiologist and computer scientist with nearly 25 years of experience in the science and technology of big data.
Read more
Sebastian is a physician and pharmacoepidemiologist with 25 years of experience in analyzing health care databases.
Read more
Lowell is the Chief Legal and Regulatory Officer of Aetion. Previously, Lowell served in several senior leadership roles at the U.S. FDA, most recently as the Principal Associate Commissioner for Policy.
Read more
Lori is an attorney with broad experience advising corporate clients in intellectual property, privacy, data security, corporate governance, and risk management.
Read more
John brings to Aetion decades of experience leading technology teams, most recently as the first CTO of Oden Technologies, a New York-based manufacturing analytics company.
Read more
Over her 20+ years in health care transformation, Liz has tackled numerous and varied go-to-market challenges across many high-growth, high-tech firms.
Read more
Richard is Chief Growth Officer to Aetion and has led business development for several health care technology companies serving the life sciences industry.
Read more
TC is Chief Financial Officer to Aetion, and his industry and corporate finance experience spans over 25 years in numerous industries.
Read more
Julie is Senior Vice President of Scientific Engagement and Delivery at Aetion and has 17 years of experience at Pfizer working to improve overall R&D productivity.
Read more
David is Chief People Officer to Aetion and has nearly 20 years of experience building and leading human resources teams across public and private companies.
Read moreOur Directors and Advisors

With more than a 20-year tenure investing in young and emerging healthcare technology companies, Bill Geary serves on boards of industry-leading companies, working closely with founders and management.
Read more
Mohamad Makhzoumi is a general partner at NEA and heads the firm’s Healthcare Services & Healthcare IT investment practice.
Read more
Dr. Scott Gottlieb is a Special Partner on the NEA healthcare investment team; he was a Venture Partner at NEA from 2007 to 2017 until being appointed the 23rd Commissioner of the U.S. Food and Drug Administration (FDA), where he served from 2017 to 2019.
Read more
Cathy Polinsky is the Chief Technology Officer at Stitch Fix. In her role as CTO, Cathy has had responsibility over Engineering, IT, Product, User Experience, and Security functions. She started in 2016 and helped take the company public in 2017.
Read more
Oliver is a partner at Lakestar Capital, based in Zurich, Switzerland. He was part of the founding Lakestar team and in 2017 was featured in the Forbes 30 Under 30 list.
Read more
Adair is a principal at Greenspring Associates and is responsible for sourcing and due diligence efforts on fund, direct, and secondary opportunities. He is also involved in Greenspring Associates’ Portfolio Impact Program.
Read more
Arvind co-leads EDBI’s investment activities in the U.S. across various sectors—enterprise SaaS, financial markets tech, health tech, and agrifood.
Read more
Shumeet Banerji is founder and partner of Condorcet, LP, an investment and advisory firm. In 2013, Shumeet retired from Booz & Company Inc., having served as its founding chief executive officer.
Read more
Mohit Misra, M.D., is a physician, trained health economist, and ex-strategy consultant with over 15 years of experience in working with health care systems and life science companies in the U.S., Europe, and Asia.
Read more
Kavita Patel, M.D., joined NEA in 2017 as a venture partner on the health care team. In addition to her role at NEA, Kavita is a practicing primary care physician at Johns Hopkins Medicine and a fellow at the Brookings Institution.
Read more
Jonathan is the senior independent non-executive director of HSBC Holdings plc, chairman of HSBC Bank plc, and chairman of HSBC Holdings’ Group Audit Committee. He also sits on the Group Risk Committee.
Read more